Prognostic Factors of Patients with Advanced Gallbladder Carcinoma Following Aggressive Surgical Resection

Journal of Gastrointestinal Surgery

Volumn 15, Issue 6, 2011, Pages 1007-1016

  Murakami, Yoshiaki ^a   Uemura, Kenichiro ^a   Sudo, Takeshi ^a   Hashimoto, Yasushi ^a   Nakashima, Akira ^a   Kondo, Naru ^a   Sakabe, Ryutaro ^a   Kobayashi, Hironori ^a   Sueda, Taijiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Adjuvant chemotherapy; Gallbladder carcinoma; Prognostic factor; R0 resection

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CARCINOMA; CHOLECYSTECTOMY; FEMALE; GALLBLADDER TUMOR; HUMAN; KAPLAN MEIER METHOD; LIVER RESECTION; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PANCREATICODUODENECTOMY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CHOLECYSTECTOMY; DEOXYCYTIDINE; FEMALE; GALLBLADDER NEOPLASMS; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREATICODUODENECTOMY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 79955791664     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-011-1479-9     Document Type: Article

References (45)

1. Jemal A, Siegel R, Xu J, et al (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Randi G, Malvezzi M, Levi F, et al (2009) Epidemiology of biliary tract cancers: an update. Ann Oncol 20: 146-159.
3. Saika K, Matsuda T (2010) Comparison of time trend in gallbladder cancer mortality (1990-2006) between countries based using the WHO mortality database. Jpn J Clin Oncol 40: 374-375.
4. Manfredi S, Benhamiche AM, Isambert N, et al (2000) Trends in incidence and management of gallbladder carcinoma: a population-based study in France. Cancer 89: 757-762.
5. Donohue JH (2001) Present status of the diagnosis and treatment of gallbladder carcinoma. J Hepatobiliary Pancreat Surg 8: 530-534.
6. Chan SY, Poon RT, Lo CM, et al (2008) Management of carcinoma of the gallbladder: a single-institution experience in 16 years. J Surg Oncol 97: 156-164.
7. Puhalla H, Wild T, Bareck E, et al (2002) Long-term follow-up of surgically treated gallbladder cancer patients. Eur J Surg Oncol 28: 857-863.
8. Ito H, Matros E, Brooks DC, et al (2004) Treatment outcomes associated with surgery for gallbladder cancer: a 20-year experience. J Gastrointest Surg 8: 183-190.
9. Kondo S, Nimura Y, Hayakawa N, et al (2002) Extensive surgery for carcinoma of the gallbladder. Br J Surg 89: 179-184.
10. Shimizu H, Kimura F, Yoshidome H, et al (2007) Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese Society of Biliary Surgery classification. J Hepatobiliary Pancreat Surg 14: 358-365.
11. Reddy SK, Marroquin CE, Kuo PC, et al (2007) Extended hepatic resection for gallbladder cancer. Am J Surg 194: 355-361.
12. Dixon E, Vollmer CM Jr, Sahajpal A, et al (2005) An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg 241: 385-394.
13. Behari A, Sikora SS, Wagholikar GD, et al (2003) Longterm survival after extended resections in patients with gallbladder cancer. J Am Coll Surg. 196: 82-88.
14. Cho SY, Kim SH, Park SJ, et al (2010) Adjuvant chemoradiation therapy in gallbladder cancer. J Surg Oncol 102: 87-93.
15. Kim WS, Choi DW, You DD, et al (2010) Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma. J Gastrointest Surg 14: 679-687.
16. Gold DG, Miller RC, Haddock MG, et al (2009) Adjuvant therapy for gallbladder carcinoma: the Mayo clinic experience. Int J Radiat Oncol Biol Phys 75: 150-155.
17. Mojica P, Smith D, Ellenhorn J (2007) Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease. J Surg Oncol 96: 8-13.
18. Czito BG, Hurwitz HI, Clough RW, et al (2005) Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys 62: 1030-1034.
19. Murakami Y, Uemura K, Sudo T, et al (2009) Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma. Ann Surg 250: 950-956.
20. Murakami Y, Uemura K, Sudo T, et al (2009) Indication for postoperative adjuvant therapy in biliary carcinoma based on analysis of recurrence and survival after surgical resection. Dig Dis Sci 54: 1360-1364.
21. Takada T, Amano H, Yasuda H, et al; Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95: 1685-1695.
22. Kayahara M, Nagakawa T (2007) Recent trends of gallbladder cancer in Japan: an analysis of 4, 770 patients. Cancer 110: 572-580.
23. Miura F, Asano T, Amano H, et al (2010) New prognostic factor influencing long-term survival of patients with advanced gallbladder carcinoma. Surgery 148: 271-277.
24. Choi SB, Han HJ, Kim CY, et al (2010) Surgical outcomes and prognostic factors for T2 gallbladder cancer following surgical resection. J Gastrointest Surg 14: 668-678.
25. Wakai T, Shirai Y, Sakata J, et al (2010) Mode of hepatic spread from gallbladder carcinoma: an immunohistochemical analysis of 42 hepatectomized specimens. Am J Surg Pathol 34: 65-74.
26. Miyakawa S, Ishihara S, Horiguchi A, et al (2009) Biliary tract cancer treatment: 5, 584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan. J Hepatobiliary Pancreat Surg 16: 1-7.
27. Shibata K, Uchida H, Iwaki K, et al (2009) Lymphatic invasion: an important prognostic factor for stages T1b-T3 gallbladder cancer and an indication for additional radical resection of incidental gallbladder cancer. World J Surg 33: 1035-1041.
28. Kayahara M, Nagakawa T, Nakagawara H, et al (2008) Prognostic factors for gallbladder cancer in Japan. Ann Surg 248: 807-814.
29. Kai M, Chijiiwa K, Ohuchida J, et al (2007) A curative resection improves the postoperative survival rate even in patients with advanced gallbladder carcinoma. J Gastrointest Surg 11: 1025-1032.
30. Yokomizo H, Yamane T, Hirata T, et al (2007) Surgical treatment of pT2 gallbladder carcinoma: a reevaluation of the therapeutic effect of hepatectomy and extrahepatic bile duct resection based on the long-term outcome. Ann Surg Oncol 14: 1366-1373.
31. Yagi H, Shimazu M, Kawachi S, et al (2006) Retrospective analysis of outcome in 63 gallbladder carcinoma patients after radical resection. J Hepatobiliary Pancreat Surg 13: 530-536.
32. Kokudo N, Makuuchi M, Natori T, et al (2003) Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg 138: 741-750; discussion 750.
33. Yamaguchi R, Nagino M, Oda K, et al (2002) Perineural invasion has a negative impact on survival of patients with gallbladder carcinoma. Br J Surg 89: 1130-1136.
34. Fong Y, Jarnagin W, Blumgart LH (2000) Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg 232: 557-569.
35. Shimada H, Endo I, Togo S, et al (1997) The role of lymph node dissection in the treatment of gallbladder carcinoma. Cancer 79: 892-899.
36. Sobin LH, Gospodarowicz MK, Wittekind C (eds). Internatinal Union Against Cancer (UICC) (2010) TNM classification of malignant tumors. 7th ed. Wiley-Blackwell, New York.
37. Murakami Y, Uemura K, Sudo T, et al (2011) Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol 18: 651-658.
38. Murakami Y, Uemura K, Sudo T, et al (2009) Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. J Gastrointest Surg 13: 1470-1479.
39. Murakami Y, Uemura K, Sudo T, et al (2008) Adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma. Am J Surg 195: 757-762.
40. Jarnagin WR, Ruo L, Little SA, et al (2003) Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 98: 1689-1700.
41. Penz M, Kornek GV, Raderer M, et al (2001) Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol 12: 183-186.
42. Valle J, Wasan H, Palmer DH, et al; ABC-02 Trial Investigators (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362: 1273-1281.
43. Sasaki T, Isayama H, Nakai Y, et al (2010) Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol 65: 1101-1107.
44. Ueno H, Okusaka T, Ikeda M, et al (2004) Phase II study of S-1 in patients with advanced biliary tract cancer. Br J Cancer 91: 1769-1774.
45. Araida T, Higuchi R, Hamano M, et al (2009) Hepatic resection in 485 R0 pT2 and pT3 cases of advanced carcinoma of the gallbladder: results of a Japanese Society of Biliary Surgery survey-a multicenter study. J Hepatobiliary Pancreat Surg 16: 204-215.